The Latest Cardiac and Vascular News
A Statement from the Heart Failure Society of America ROCKVILLE, Md., April 23, 2020 /PRNewswire/ — The COVID-19 pandemic presents an unprecedented crisis for patients, clinicians, and healthcare systems. Most US healthcare systems have reduced ambulatory outpatient clinics – pillars of the longitudinal care of patients with chronic illnesses. In this context, […]
– Orenitram demonstrated improvement in hemodynamic parameters and risk status, important indicators of long-term outcomes in PAH patients, in presentations at recent scientific conferences – Separately, total PAH-related patient healthcare costs are 67% higher for selexipag in article published in Drugs – Real World Outcomes SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, […]
PORTLAND, Ore., April 23, 2020 /PRNewswire/ — VisCardia Inc., a privately held medical device developer, announced today it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its implantable VisONE® system designed for the treatment of moderate to severe heart failure with reduced ejection fraction and preserved ventricular […]
Alliance and Equity Investment Improves Access to Remote Patient Care for 70 Percent of the Global Population MOUNTAIN VIEW, Calif. and KYOTO, Japan, April 23, 2020 /PRNewswire/ — AliveCor, a leader in personal ECG products, and OMRON Healthcare, Co., Ltd., a global leader in personal heart health and wellness technology, today announced a global, strategic alliance […]
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the first commercial use of its Tack Endovascular System® (4F) in multiple sites across the United States. Notably the first FDA-approved vascular implant for below-the-knee post-angioplasty dissection repair, Tack® implants are designed to optimize balloon […]
BASKING RIDGE, N.J., April 22, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), today announced that it has finalized an agreement to sell $10.9 million in New Jersey net operating losses (“NJ NOLs”) to a qualifying and approved buyer pursuant to the New Jersey Economic […]
Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) — Former senior executive at AstraZeneca and pharmaceutical industry expert to join as Independent Director The Company is developing Vicromax(tm) – a broad-spectrum orally administered anti-viral candidate for COVID-19 Upon receipt of FDA approval, Phase II clinical trial is planned to be conducted at […]
Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, United Kingdom, April 22, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its Neqstent™ Coil Assisted Flow Diverter device, designed to treat […]
Solution enables sponsors and sites to continuously monitor axillary body temperature while the patient is at home or in a clinical research unit CAMPBELL, Calif., April 22, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, and Bioclinica, the leader in Medical Imaging, Cardiac Safety services and technology-enabled solutions in clinical research, […]
Trial will evaluate use of Cardiologs’ AI platform for QT interval analysis of ECG data from smartwatches in patients receiving hydroxychloroquine treatment BOSTON, April 22, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, today announced the launch of a clinical study using the company’s ground-breaking AI-based solution […]
